IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Dec 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-11-29

Reporting Person: POLEWACZYK JAMES F (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-29	Common Stock	S	4595	$633	Disposed	14818.2845	Direct

Footnotes

F1: Updated to correct a scrivener's error in the Form 4 filed on August 25, 2021, which inadvertently reported the total amount of beneficially owned securities following the reported transaction as 19,494.2845 instead of 19,404.2845. Also includes 9 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021.